BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34205606)

  • 1. Understanding Amyloid Structures and Disease: A Continuing Challenge in Health Research.
    Chiellini G
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Diagnostic Potential of Amyloidogenic Proteins.
    Jin Y; Vadukul DM; Gialama D; Ge Y; Thrush R; White JT; Aprile FA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy Modulation as a Treatment of Amyloid Diseases.
    Mputhia Z; Hone E; Tripathi T; Sargeant T; Martins R; Bharadwaj P
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31527516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propagation of Protein Aggregation in Neurodegenerative Diseases.
    Vaquer-Alicea J; Diamond MI
    Annu Rev Biochem; 2019 Jun; 88():785-810. PubMed ID: 30917002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloids and Amyloid-like Protein Aggregates in Foods: Challenges and New Perspectives.
    Malik S; Yadav JK
    Curr Protein Pept Sci; 2023; 24(5):393-403. PubMed ID: 36600621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in vivo conditions on amyloid aggregation.
    Owen MC; Gnutt D; Gao M; Wärmländer SKTS; Jarvet J; Gräslund A; Winter R; Ebbinghaus S; Strodel B
    Chem Soc Rev; 2019 Jul; 48(14):3946-3996. PubMed ID: 31192324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and Aggregation Mechanisms in Amyloids.
    Almeida ZL; Brito RMM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32155822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenesis: What Do We Know So Far?
    Alraawi Z; Banerjee N; Mohanty S; Kumar TKS
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
    Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
    Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disentangling a Bad Reputation: Changing Perceptions of Amyloids.
    Wang M; Audas TE; Lee S
    Trends Cell Biol; 2017 Jul; 27(7):465-467. PubMed ID: 28359692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein aggregation and ER stress.
    Ogen-Shtern N; Ben David T; Lederkremer GZ
    Brain Res; 2016 Oct; 1648(Pt B):658-666. PubMed ID: 27037184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.
    Skovronsky DM; Lee VM; Trojanowski JQ
    Annu Rev Pathol; 2006; 1():151-70. PubMed ID: 18039111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrogating Amyloid Aggregates using Fluorescent Probes.
    Aliyan A; Cook NP; Martí AA
    Chem Rev; 2019 Dec; 119(23):11819-11856. PubMed ID: 31675223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular chaperones biochemistry and role in neurodegenerative diseases.
    Chaari A
    Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle titin forms in vitro amyloid aggregates.
    Bobylev AG; Galzitskaya OV; Fadeev RS; Bobyleva LG; Yurshenas DA; Molochkov NV; Dovidchenko NV; Selivanova OM; Penkov NV; Podlubnaya ZA; Vikhlyantsev IM
    Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Horvath I; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12473-12477. PubMed ID: 27791129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
    Glabe CG
    Neurobiol Aging; 2006 Apr; 27(4):570-5. PubMed ID: 16481071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.